Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs DISHMAN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA DISHMAN PHARMA GSK PHARMA/
DISHMAN PHARMA
 
P/E (TTM) x 62.2 30.0 207.5% View Chart
P/BV x 18.9 3.3 564.2% View Chart
Dividend Yield % 1.6 0.7 247.9%  

Financials

 GSK PHARMA   DISHMAN PHARMA
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
DISHMAN PHARMA
Mar-16
GSK PHARMA/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,684374 449.7%   
Low Rs1,231129 954.8%   
Sales per share (Unadj.) Rs191.9197.0 97.4%  
Earnings per share (Unadj.) Rs35.921.2 169.3%  
Cash flow per share (Unadj.) Rs39.834.7 114.5%  
Dividends per share (Unadj.) Rs32.002.00 1,600.0%  
Avg Dividend yield %2.20.8 276.3%  
Book value per share (Unadj.) Rs102.9179.9 57.2%  
Shares outstanding (eoy) m169.4180.70 209.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.61.3 594.3%   
Avg P/E ratio x40.611.9 342.1%  
P/CF ratio (eoy) x36.77.3 505.6%  
Price / Book Value ratio x14.21.4 1,012.4%  
Dividend payout %89.29.4 945.2%   
Avg Mkt Cap Rs m246,85820,307 1,215.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9505,355 111.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,51715,898 204.5%  
Other income Rs m1,007265 379.3%   
Total revenues Rs m33,52416,163 207.4%   
Gross profit Rs m8,0334,103 195.8%  
Depreciation Rs m6581,091 60.3%   
Interest Rs m18944 1.9%   
Profit before tax Rs m8,3642,334 358.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,288624 366.8%   
Profit after tax Rs m6,0761,710 355.3%  
Gross profit margin %24.725.8 95.7%  
Effective tax rate %27.426.7 102.3%   
Net profit margin %18.710.8 173.7%  
BALANCE SHEET DATA
Current assets Rs m24,94311,018 226.4%   
Current liabilities Rs m13,2649,517 139.4%   
Net working cap to sales %35.99.4 380.4%  
Current ratio x1.91.2 162.4%  
Inventory Days Days9757 170.7%  
Debtors Days Days2163 6,174.2%  
Net fixed assets Rs m6,98818,787 37.2%   
Share capital Rs m1,694161 1,049.6%   
"Free" reserves Rs m15,73514,354 109.6%   
Net worth Rs m17,43014,516 120.1%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m31,93029,805 107.1%  
Interest coverage x462.63.5 13,327.3%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x1.00.5 190.9%   
Return on assets %19.18.9 214.3%  
Return on equity %34.911.8 295.9%  
Return on capital %48.117.5 274.4%  
Exports to sales %024.9 0.0%   
Imports to sales %48.13.7 1,285.8%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs m15,630594 2,630.0%   
Fx inflow Rs m1,6224,952 32.8%   
Fx outflow Rs m15,630697 2,243.4%   
Net fx Rs m-14,0084,255 -329.2%   
CASH FLOW
From Operations Rs m4,8422,786 173.8%  
From Investments Rs m8,079-1,529 -528.4%  
From Financial Activity Rs m-15,433-941 1,640.1%  
Net Cashflow Rs m-2,512317 -793.8%  

Share Holding

Indian Promoters % 0.0 61.4 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 23.0 50.5%  
FIIs % 2.9 12.0 24.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 38.6 64.8%  
Shareholders   114,663 52,291 219.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs Dishman Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs Dishman Pharma Share Price Performance

Period GSK Pharma Dishman Pharma S&P BSE HEALTHCARE
1-Day 3.26% 2.87% 1.18%
1-Month -9.77% -2.45% -0.75%
1-Year 52.63% 96.38% 61.82%
3-Year CAGR 10.89% 89.34% 18.16%
5-Year CAGR 8.44% 38.20% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the Dishman Pharma share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of Dishman Pharma the stake stands at 61.4%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of Dishman Pharma.

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

Dishman Pharma paid Rs 2.0, and its dividend payout ratio stood at 9.4%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of Dishman Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.